Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
37m
on MSN
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
Medicine Buffalo
25m
UB pharmacy professor discusses pros and cons of popular weight-loss drugs
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
37m
on MSN
Pfizer going 'all in' on obesity drug development, CEO Bourla says
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge allows report release
LA wildfires death toll rises
California fires: How to help
Calls for special session
SCOTUS rebuffs appeal
Fury announces retirement
Frozen taquitos recalled
Eases environmental laws
Allows Hawaii climate suits
'Struggling to make a living'
Netflix delays Markle's show
Chicago's gunshot pilot
Eagles defeat Packers
6.9 earthquake jolts Japan
Biden speaks w/ Netanyahu
Scrap Center City arena plan
Winds topple bridge fencing
Pledge deeper cooperation
Photographer Toscani dies
Wins Sony Open playoff
Bannon derides Musk
At least 40 farmers killed
Italy releases Iranian man
Milanović wins another term
New rules on AI chip exports
Prospect files for bankruptcy
LAUSD schools reopen
New Glenn rocket delayed
Related topics
Ozempic
Wegovy
Eli Lilly and Company
Zepbound
Novo Nordisk
Feedback